“…Epidemiological studies have demonstrated that rotavirus G serotypes G1, G2, G3, G4, and P serotypes P1A [8], P1B[4] are the most frequent types associated with disease globally, and are thus the targets for vaccine development [Hoshino and Kapikian, 2000;Kapikian et al, 2001;Hoshino et al, 2002]. Occasionally, unusual rotavirus serotypes, such as G5 and G8, may be locally widespread [Gouvea et al, 1994;Leite et al, 1996;Adah et al, 1997;Nakata et al, 1999;Steele et al, 1999Steele et al, , 2002Hoshino and Kapikian, 2000;Palombo et al, 2000a], whereas evidence has been collected showing a global spread of the G9 serotype, that is considered the fifth most common rotavirus G type worldwide [Leite et al, 1996;Ramachandran et al, 1996Ramachandran et al, , 1998Arista et al, 1997;Unicomb et al, 1999;Bon et al, 2000;Cubitt et al, 2000;Maneekarn and Ushijima, 2000;O'Halloran et al, 2000;Oka et al, 2000;Palombo et al, 2000b;Widdowson et al, 2000;Bok et al, 2001;Cascio et al, 2001;Santos et al, 2001;Cunliffe et al, 2001a,b;Kang et al, 2002;Steele et al, 2002] (V. Martella, personal observations). The mechanisms driving evolution of rotaviruses are various and accumulation of single-point substitutions and reassortment are most likely involved in generating variability [Estes, 2001].…”